H.202
An act relating to increasing the transparency of prescription drug costs and spending
2025-2026 Session
Change SessionH.202
An act relating to increasing the transparency of prescription drug costs and spending
- Sponsor(s)
- Location
- House Committee on Health Care
- Last Recorded Action
- House 2/12/2025 - Read first time and referred to the Committee on Health Care
Bill/Resolution Text
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to increasing the transparency of prescription drug costs and spending
Detailed Status
Regular Session 2025-2026
An act relating to increasing the transparency of prescription drug costs and spending
Roll Call History
Regular Session 2025-2026
| Body | Date | Journal | Location | Full Status |
|---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to increasing the transparency of prescription drug costs and spending
Committee Meetings
Regular Session 2025-2026
An act relating to increasing the transparency of prescription drug costs and spending
Meeting Full List
Regular Session 2025-2026
Friday, February 21, 2025
- Committee(s):
- House Committee on Health Care
- 10:45 AM
-
H.202 - An act relating to increasing the transparency of prescription drug costs and spending
Introduction
Rep. Mari Cordes, Sponsor
Thursday, February 27, 2025
- Committee(s):
- House Committee on Health Care
- 11:00 AM
-
H.202 - An act relating to increasing the transparency of prescription drug costs and spending
Walk-though of Sections 3 and 4
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
- 11:15 AM
-
H.202 - An act relating to increasing the transparency of prescription drug costs and spending
Kathryn O'Neill, Director of Prescription Drug Pricing, Green Mountain Care Board
Noah Montemarano, Health Policy Analyst, Green Mountain Care Board
Charles Becker, Staff Attorney, Office of the Health Care Advocate, Vermont Legal Aid
Committee Documents
An act relating to increasing the transparency of prescription drug costs and spending
Witnesses Who Testified
Regular Session 2025-2026
House Committee on Health Care
- Charles Becker, Staff Attorney, Office of the Health Care Advocate, Vermont Legal Aid
- Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
- Rep. Mari Cordes, Sponsor
- Noah Montemarano, Health Policy Analyst, Green Mountain Care Board
- Kathryn O'Neill, Director of Prescription Drug Pricing, Green Mountain Care Board
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
No fiscal documents found for H.202 in the Regular Session 2025-2026.
No committee of conference members found for H.202 in the Regular Session 2025-2026.
An act relating to increasing the transparency of prescription drug costs and spending
Committee of Conference Meetings
Regular Session 2025-2026
| Meeting Date | Committee |
|---|
